Omega-3 blood screening in early pregnancy

This study tests a new blood test to track how the body responds to treatment during pregnancy, especially for those at risk of high blood pressure conditions. It may help doctors monitor and improve care.

This study tests a new blood test during early pregnancy that can screen for certain genetic conditions by analyzing fetal cells. A simple blood draw may help detect potential chromosomal abnormalities earlier and more safely than traditional methods.

This study looks at mineral (micronutrient) levels in women during early pregnancy to understand how minerals change in the body. It may help researchers learn whether mineral status is linked to healthy pregnancy outcomes.

This trial tests whether taking omega-3 supplements can improve pregnancy outcomes and reduce inflammation in pregnant women living with HIV who are on antiretroviral therapy. If you are between 20 and 29 weeks pregnant with a single baby, you may be eligible to join.

This study tests a supplement containing omega-3 fats to see how it affects levels of DHA and EPA in your blood. If you're a healthy adult, you might join to help learn if this supplement can boost these important fats.

This study looks at whether fatty acids from the mother are linked to the risk of retinopathy of prematurity, an eye condition that can affect very premature babies. It involves checking factors related to how the body responds to fatty acids during pregnancy and comparing mothers in different pregnancy situations.